The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma

SIMPLE SUMMARY: The identification of diagnostic and prognostic biomarkers for the management of patients with hepatocellular carcinoma is an unmet need. Here we investigate the potential clinical utility of the measurement of serum epidermal growth factor receptor 3 (i.e., ERBB3) in hepatitis C vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Caviglia, Gian Paolo, Abate, Maria Lorena, Rolle, Emanuela, Carucci, Patrizia, Armandi, Angelo, Rosso, Chiara, Olivero, Antonella, Ribaldone, Davide Giuseppe, Tandoi, Francesco, Saracco, Giorgio Maria, Ciancio, Alessia, Bugianesi, Elisabetta, Gaia, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999043/
https://www.ncbi.nlm.nih.gov/pubmed/33799723
http://dx.doi.org/10.3390/biology10030215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999043/
https://www.ncbi.nlm.nih.gov/pubmed/33799723
http://dx.doi.org/10.3390/biology10030215

Ejemplares similares